By Tony Fong

Led by a mass spec business that saw the "biggest margin improvement" of any of Bruker's businesses last year, the company this week reported a 16-percent increase in company-wide revenue for the fourth quarter.

For the three months ended Dec. 31, 2009, the firm posted receipts of $366.4 million, up from $315.2 million in the year-ago period. On a currency-adjusted basis, revenue was up 6 percent.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Browse our free articles
You can still register for access to our free content.